(71 days)
Used in the manufacture of dental prosthetics: crowns, bridges, inlays, and onlays.
Xceram® is a pre-formed material for use by dental laboratories in filling orders/prescriptions for dental prosthetics
The provided text does not contain information about studies proving that the "Xceram®" device meets specific acceptance criteria.
Instead, the document is a 510(k) summary for a dental material where the claim of substantial equivalence to predicate devices is based on:
- Comparisons of formulations
- Mechanical characteristics
- Intended uses
- Identification of porcelain powders in 21 CFR 872.6660
Therefore, I cannot fulfill your request for the tables and details regarding acceptance criteria and a study proving their fulfillment. The section "Performance Data" explicitly states "None required" and explains the basis for substantial equivalence without referencing a performance study or acceptance criteria in the context of device performance.
{0}------------------------------------------------
510(K) Summary, K100250
This 510(k) summary for Xceram® material is submitted in accordance with the requirements of SMDA 1990 and follows Office of Device Evaluation guidance concerning the organization and content of a 510(k) summary.
Applicant: XceramUSA
Contact: Solomon Menashi 34 Halcvon Road Newton MA 02459 USA Tel 1-617-331-9210
APPR - 8 2010
Manufacturer: Xceram® (Luxembourg)
Preparation Date: January 19, 2010
Device Name: Xceram@@ Common Name: Dental Frame Material for Dental Prosthesis Classification Information:
Porcelain, powder for clinical use CFR: 21 CFR 872.6660 Class: Class II medical device Product Code: EIH Panel: Dental
K070537 ZirBlock®, CDL Technologies; K092513 Rainbow Block, Genoss Predicate devices: Co. Ltd .; K092630 Zirox, Zencera, Inc.
Device description: Xceram® is a pre-formed material for use by dental laboratories in filling orders/prescriptions for dental prosthetics
Indications: Xceram® is used in the manufacture of dental prosthetics: crowns, bridges, inlays, and onlays.
Performance Data: None required. The claim of substantial equivalence is based on comparisons of formulations, mechanical characteristics, and intended uses of the devices to legally marketed predicates and to the IDENTIFICATION of porcelain powders in 21 CFR 872.6660.
Based on the information in the premarket notification, Xceram®USA CONCLUSION: believes that the Xceram® device is substantially equivalent to cited legally marketed predicates and to the IDENTIFICATION in the classifying regulation (21 CFR 872.6660).
{1}------------------------------------------------
Image /page/1/Picture/1 description: The image shows the seal of the Department of Health & Human Services USA. The seal features a stylized eagle with three wing-like shapes, representing health, human services, and well-being. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" is arranged in a circular pattern around the eagle.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
XceramUSA C/O Mr. Daniel Kamm Principal Consultant Kamm & Associates 8726 Ferrara Court Naples, Florida 34114
APR - 8 2010
Re: K100250
Trade/Device Name: Xceram® Regulation Number: 21 CFR 872.6660 Regulation Name: Porcelain Powder for Clinical Use Regulatory Class: II Product Codes: EIH Dated: January 20, 2010 Received: January 27, 2010
Dear Mr. Kamm:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.\
{2}------------------------------------------------
Page 2 – Mr. Kamm
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to
http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
for
Anthony D. Watson, B.S., M.S., M.B.A. Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and
Radiological Health
Enclosure
{3}------------------------------------------------
Indications for Use
510(k) Number (if known): K100 2 5 0
Device Name: Xceram®
Indications For Use:
Used in the manufacture of dental prosthetics: crowns, bridges, inlays, and onlays.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
RSBETZINS for Dr. K. Pinuly.
Division Sign-Off) livision of Anesthesiology, General Hospital ifection Control, Dental Devices
Page 1 of 1
:10(k) Number: K100250
§ 872.6660 Porcelain powder for clinical use.
(a)
Identification. Porcelain powder for clinical use is a device consisting of a mixture of kaolin, felspar, quartz, or other substances intended for use in the production of artificial teeth in fixed or removable dentures, of jacket crowns, facings, and veneers. The device is used in prosthetic dentistry by heating the powder mixture to a high temperature in an oven to produce a hard prosthesis with a glass-like finish.(b)
Classification. Class II.